MLV & Co Upgrades Acura Pharmaceuticals To Buy By: Benzinga via Benzinga February 27, 2015 at 08:59 AM EST Analysts MLV & Co upgraded Acura Pharmaceuticals, Inc. (NASDAQ: ACUR) from Hold to Buy. The price target for Acura Pharmaceuticals is ... Read More >>